In the US, Tetrabenazine (tetrabenazine systemic) is a member of the drug class miscellaneous central nervous system agents and is used to treat Huntington's Disease.
US matches:
- Tetrabenazine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
,N05AK01
CAS registry number (Chemical Abstracts Service)
0000058-46-8
Chemical Formula
C19-H27-N-O3
Molecular Weight
317
Therapeutic Category
Neuroleptic
Chemical Names
(RS)-2,3,4,6,7,11b-Hexahydro-3-isobutyl-9-10-dimethoxy-1H-benzo[a]chinolizin-2-on (IUPAC)
1,2,3,4,6,7-hexahydro-3-isobutyl-9,10-dimethoxy-2-oxo-11bH-benzo[a]quinolizine (WHO)
1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one (WHO)
2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-
2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-
2-oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine
9,10-Dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizin-2-one (BAN)
Foreign Names
- Tetrabenazinum (Latin)
- Tetrabenazin (German)
- Tétrabénazine (French)
- Tetrabenazina (Spanish)
Generic Names
- Tetrabenazine (OS: BAN)
- 5-21-13-00178 (IS: Beilstein)
- AI3-52046 (IS)
- BRN 0040090 (IS)
- EINECS 200-383-6 (IS)
- NSC 169886 (IS)
- Ro 1-9569 (IS)
Brand Names
- Nitoman
Cambridge, Ireland; MediLink, Denmark; Prestwick, Canada; Temmler, Germany; UCB, Spain; UCB, Portugal - Revocon
Sun, India - Tetrabenazine
Orphan, Australia - Xenazine
AFT, New Zealand; Biovail, United States; Cambridge Laboratories, United Kingdom; Megapharm, Israel; Orphan OPi, France; Prestwick, United States; ProReo Pharma, Switzerland
International Drug Name Search
Glossary
BAN | British Approved Name |
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment